Cargando…
HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial
BACKGROUND: Gastrointestinal bleeding is a common emergency that causes substantial mortality worldwide. Acute upper and lower gastrointestinal bleeding accounts for about 75,000 hospital admissions each year in the UK and causes the death of about 10% of these patients. Tranexamic acid has been sho...
Autores principales: | Roberts, Ian, Coats, Timothy, Edwards, Phil, Gilmore, Ian, Jairath, Vipul, Ker, Katharine, Manno, Daniela, Shakur, Haleema, Stanworth, Simon, Veitch, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253634/ https://www.ncbi.nlm.nih.gov/pubmed/25409738 http://dx.doi.org/10.1186/1745-6215-15-450 |
Ejemplares similares
-
Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial
por: Brenner, Amy, et al.
Publicado: (2019) -
Economic evaluation of tranexamic acid for the treatment of acute gastrointestinal bleeding: a cost-effectiveness analysis using data from the HALT-IT randomised controlled trial
por: Bazeer, Nuha, et al.
Publicado: (2022) -
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
por: Ker, Katharine, et al.
Publicado: (2012) -
Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms
por: Roberts, Ian, et al.
Publicado: (2017) -
Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial
por: Ker, Katharine, et al.
Publicado: (2012)